MedPath

Effectiveness of Non-pharmacological Interventions in Patients With Cardiovascular Risk Factors in Primary Care

Not Applicable
Completed
Conditions
Cardiovascular Disease
Interventions
Behavioral: therapeutic exercise
Device: ABPM ambulatory blood pressure monitoring
Registration Number
NCT03452709
Lead Sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Brief Summary

The principal objective is analyzed whether a selective intervention no pharmacological (use of ABPM +/- prescription of physical exercise) for cardiovascular risk factors in patients with high cardiovascular risk in primary prevention is associated with a decrease in cardiovascular risk measured using the risk Score tables for countries with a low risk. It will be independently analized the effectiveness of systematic use of ABPM and the prescription of physical exercise.

Detailed Description

Cardiovascular disease continues to be the main cause of death in Western countries, with a very high prevalence (affecting \>1 in every 3 adult Americans), and contributes as one of the highest annual healthcare costs. There is still enormous potential for improving prevention although notable efforts have already been made. In the Spanish population, the following cardiovascular risk factors have been identified as being most prevalent: arterial hypertension, dyslipidemia, having a sedentary lifestyle, tobaccoism, obesity and diabetes.

Essential Arterial Hypertension (EAH) is the most prevalent cardiovascular risk factor in the world and the main cause of cardiovascular disease. There are many clinical practice guides which recommend carrying out moderate physical activity to prevent, delay or reduce hypertension, given that the practice of community interventions with physical activity have been efficient.

The indication to perform Itinerant Monitorization blood pressure in the diagnosis of hypertension is included in the latest draft of the clinical practice guideline from NICE, National Institute for Health and Clinical Excellence .

Other cardiovascular risk factor to take into account is dyslipidemia, the prevalence of dyslipidemia is 16.2% in adults aged over 20 years. For this condition, physical activity is also recommended.

When faced with a sedentary lifestyle or physical inactivity two intervention measures are available for reducing its incidence: verbal healthcare advice (taking advantage of the patients visit to the consultation) and the prescription of physical exercise.

Taking into account the interventions mentioned that can be carried out in the face of risk factors, and that a multifactorial intervention is more efficient that individual interventions, the investigators have designed a clinical trial which attempts to improve most of the principal risk factors. The objective is to reduce the cardiovascular risk of patients using a multifactorial intervention on hypertension, dyslipidemia, sedentary lifestyle. The investigators will evaluate the efficiency of a program for official prescriptions for physical exercise compared to structured verbal advice in hypertense patients undergoing treatment and who have another risk factors (dyslipidemia being treated for more than one year or they are smokers), including action to improve the treatment adaptation for the hypertension (ABPM).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3656
Inclusion Criteria
  • Undergoing treatment with at least one hypertense drug due to HTA and at least one hypolipemiant drug prescribed due to hypercholesterolemia, or other risk factor. The treatment should have a minimum duration time of 12 months prior to inclusion in the study.
  • Patient in Primary Prevention.
  • Finding oneself in the sedentary lifestyle category or through activation of the simplified active questionnaire of physical activity extracted from the Lipid Research Clinics prevalence Study
Exclusion Criteria
  • Serious or terminal diseases.
  • Diagnosis of ischemic and/or cerebrovascular cardiopathy.
  • Patients with a limiting pathology which prevents physical exercise being performed.
  • Serious mental illnesses: Psychosis, Major depressive disorder, Neurosis.
  • Diabetes mellitus.
  • Patients with limiting pathology preventing them from carrying out physical exercise.
  • Serious mental diseases: Psychosis, Major depresive disorder, Neurosis.
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
therapeutic exercise + ABPMABPM ambulatory blood pressure monitoring-
therapeutic exercisetherapeutic exerciseIn this group the intervention is the prescription of physical activity. The duration of the groups is planned to be from 12 weeks with 3 programmed sessions per week.
ABPMABPM ambulatory blood pressure monitoringIn this group the arterial pressure is evaluated with ABPM.
therapeutic exercise + ABPMtherapeutic exercise-
Primary Outcome Measures
NameTimeMethod
Cardiovascular risk .Every 3 months , up to 12 months.

Tables for countries with low cardiovascular risk

Systolic arterial tensionEvery 3 months , up to 12 months

blood pressure

Secondary Outcome Measures
NameTimeMethod
diastolic arterial tensionEvery 3 months , up to 12 months

blood pressure

Cholesterol levels.Every 3 months , up to 12 months

blood levels.

Physical ActivityEvery 3 months , up to 12 months

International Physical Activity Questionniare (IPAQ) 600-3000 MET (METs are multiples of the resting metabolic rate

EUROFIT batteryEvery 3 months , up to 12 months

Score obtained

Pharmacological treatment.Every 3 months , up to 12 months

Number of antihypertensive and hypolipemiant drug and dose.

Trial Locations

Locations (1)

Fundación para la Formación e Investigación Sanitarias de la Región de Murcia

🇪🇸

Murcia, Comunidad Autonoma De La Region De Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath